| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Division of Cardiology, Department of Rehabilitation Medicine, Center for Women's Health, College of Physicians and Surgeons, Columbia University, New York, New York 10032
The pathogenesis of blood pressure (BP) rise in aging women remains unexplained, and one of the many incriminating factors may include abnormalities in arteriolar resistance vessels. The aim of this study was to determine the effects of unopposed estrogen on arteriolar distensibility, baroreceptor sensitivity (BRS), BP changes, and rate-pressure product (RPP). We tested the hypotheses that estrogen replacement therapy (ERT) enhances arteriolar distensibility and ameliorates BRS, which leads to decreases in BP and RPP. Postmenopausal women participated in a single-blind crossover study; the participants of this study, after baseline measurements, were randomly assigned to receive estrogen (ERT) or a drug-free treatment with a 6-wk washout period between treatments. The single-blind design was instituted because subjects become unblinded due to physiological changes (i.e., fluid shifts, weight gain, and secretory changes) associated with estrogen intake. However, investigators and technicians involved in data collection and analyses remained blind. After each treatment, subjects performed identical autonomic tests, during which electrocardiograms, beat-by-beat BPs, and respiration were recorded. The area under the dicrotic notch of the BP wave was used as an index of arteriolar distensibility. The magnitude of the reflex bradycardia after a precipitous rise in BP was used to determine BRS. Power spectral analysis of heart rate variability was used to assess autonomic activity. BPs were recorded from resistance vessels in the finger using a beat-by-beat photoplethysmographic device. RPP, a noninvasive marker of myocardial oxygen consumption, was calculated. Repeated-measures analyses of variance revealed a significantly enhanced arteriolar distensibility and BRS after ERT (P < 0.05). A trend of a lower sympathovagal balance at rest was observed after ERT; however, this trend did not reach statistical significance (P = 0.061) compared with the other treatments. The above autonomic changes produced significantly lower systolic and diastolic BP changes and RPPs (P < 0.05) at rest and during isometric exercise. We conclude that short-term unopposed ERT favorably enhances arteriolar distensibility, BRS, and hemodynamic parameters in postmenopausal women. These findings have clinical implications in the goals for treating cardiovascular risk factors in aging women.
baroreceptor sensitivity; blood pressure changes
This article has been cited by other articles:
|
|
 |
|
  R. K. Goldman, A. S. Azar, J. M. Mulvaney, C. Hinojosa-Laborde, J. R. Haywood, and V. L. Brooks Baroreflex sensitivity varies during the rat estrous cycle: role of gonadal steroids Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1419 - R1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Oneda, C. L. M. Forjaz, F. R. Bernardo, T. G. Araujo, J. L. Gusmao, E. Labes, S. B. Abrahao, D. Mion Jr., A. M. Fonseca, and T. Tinucci Low-dose estrogen therapy does not change postexercise hypotension, sympathetic nerve activity reduction, and vasodilation in healthy postmenopausal women Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1802 - H1808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Liu, T. B. J. Kuo, and C. C. H. Yang Effects of estrogen on gender-related autonomic differences in humans Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2188 - H2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fang, S. H. Carlson, Y. F. Chen, S. Oparil, and J. M. Wyss Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1934 - R1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Saleh, A. E. Cribb, and B. J. Connell Reduction in infarct size by local estrogen does not prevent autonomic dysfunction after stroke Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R2088 - R2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Roberts, N. D. Vaziri, and R. J. Barnard Protective effects of estrogen on gender-specific development of diet-induced hypertension J Appl Physiol, November 1, 2001; 91(5): 2005 - 2009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Vongpatanasin, M. Tuncel, Y. Mansour, D. Arbique, and R. G. Victor Transdermal Estrogen Replacement Therapy Decreases Sympathetic Activity in Postmenopausal Women Circulation, June 19, 2001; 103(24): 2903 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Hunt, J. A. Taylor, J. W. Hamner, M. Gagnon, and L. A. Lipsitz Estrogen Replacement Therapy Improves Baroreflex Regulation of Vascular Sympathetic Outflow in Postmenopausal Women Circulation, June 19, 2001; 103(24): 2909 - 2914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. Minson, J. R. Halliwill, T. M. Young, and M. J. Joyner Sympathetic Activity and Baroreflex Sensitivity in Young Women Taking Oral Contraceptives Circulation, September 26, 2000; 102(13): 1473 - 1476. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
